We are live on ! Find out more
OR

Olympiad Research Portfolio holdings

AUM $48.1M
1-Year Est. Return 100.39%
This Fund
S&P 500
This Quarter Est. Return
+5.74%
1 Year Est. Return
+100.39%
3 Year Est. Return
+188.76%
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
+$17.8M
Cap. Flow
+$14.3M
Cap. Flow %
9.32%
Top 10 Hldgs %
14.09%
Holding
503
New
162
Increased
64
Reduced
67
Closed
185

Top Buys

Rank Stock Value
1
SRDX
Surmodics
SRDX
+$1.97M
2
TELL
Tellurian Inc.
TELL
+$1.78M
3
K
Kellanova
K
+$1.77M
4
BALY icon
Bally's
BALY
+$1.58M
5
EVRI
Everi Holdings
EVRI
+$1.35M

Sector Composition

Rank Sector Weight
1 Technology 32.55%
2 Consumer Discretionary 16.26%
3 Industrials 13.1%
4 Energy 10.97%
5 Financials 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOLI
501
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-21,834
Closed -$472K
ETRN
502
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
-160,128
Closed -$2.08M
CATC
503
DELISTED
CAMBRIDGE BANCORP
CATC
-3,853
Closed -$266K

Similar funds

Olympiad Research's Q3 2024 Portfolio in Review

As of Q3 2024, Olympiad Research held 503 positions worth $154M, up 13% from $136M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Olympiad Research deployed $14.3M of net new capital in Q3 2024, opening 162 new positions and adding to 64 existing holdings. Its largest new stake was Surmodics: 48,591 shares worth $1.88M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Clear Secure, an estimated $375K trimmed.

  • Olympiad Research's largest Q3 2024 buy was Surmodics: 48,591 shares worth $1.88M.
  • Olympiad Research added most to Bally's in Q3 2024, an estimated $1.58M increase.
  • Olympiad Research's biggest Q3 2024 reduction was Clear Secure, cutting an estimated $375K.
  • Olympiad Research fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $2.14M.
  • Olympiad Research's ten largest holdings make up 14% of its $154M portfolio in Q3 2024.
  • Olympiad Research opened 162 new positions and closed 185 in Q3 2024.
  • Olympiad Research's portfolio value rose 13% quarter-over-quarter to $154M.

Based on Olympiad Research's 13F filing for Q3 2024, filed 31 Oct 2024.